One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2020-135818
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 26 |
Affiliation: Memorial Sloan Kettering Cancer Center, Royal Hobart Hospital, Tennessee Oncology, Sarah Cannon, Roche (Canada), Asan Medical Center, University of Ulsan, Ulsan College, Royal Adelaide Hospital, University of Melbourne, St Vincent's Hospital, University of California, San Diego, Washington University in St. Louis, Jewish General Hospital, Hackensack University Medical Center, Linear Clinical Research, Sir Charles Gairdner Hospital, City Of Hope National Medical Center
Subcutaneous Mosunetuzumab in Relapsed or Refractory B-Cell Lymphoma: Promising Safety and Encouraging Efficacy in Dose Escalation Cohorts
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
